Integrated Testing Strategy for Simultaneous Detection of ESR-1 and GBRCA Mutations Via Liquid Biopsy in HR+/HER2- Metastatic Breast Cancer (mBC) Patients,

RecruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

December 20, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2030

Conditions

Breast Cancer, Metastatic

Trial Locations (1)

RECRUITING

European Institute of oncology, Milan

All Listed Sponsors

lead

European Institute of Oncology

OTHER